- Price outlook for Injective (INJ) as Republic expands RWA integrations.
- INJ token is trading around $13.38 after dropping from recent highs of $16 amid a crypto sell-off.
- Anticipation of ETFs, growth in tokenization, and other catalysts may support INJ bulls.
As of Thursday night, the price of Injective hovers around $13.38, reflecting a decline of approximately 3% in the last 24 hours and over 12% in the past week. The integration with Republic raises questions about whether the INJ price could rebound to $20.
Recently, Injective’s price fell from a peak of $16, exacerbated by selling pressure in the crypto market.
This comes despite notable achievements within the finance-focused layer 1 blockchain ecosystem.
With the backing of Republic, a leading tokenized investment platform, bullish sentiments could push prices higher if market trends turn positive.
Injective’s Integration with Republic
As the cryptocurrency market faces challenges, platforms are taking the time to build connections.
Integrations are critically important, and Injective has secured a significant one through its official partnership with Republic.
The collaboration, announced on August 21, aims to incorporate Injective’s layer 1 ecosystem into Republic’s on-chain investment infrastructure.
Specifically, this integration allows projects on Injective to raise funds via Republic’s Launchpad, manage assets using Republic Wallet, and gain support from Republic’s validators.
Why is this Integration Significant?
The partnership builds on a previous collaboration where Republic became an INJ validator.
Most importantly, this integration marks a step forward in expanding on-chain private markets.
“With over 3 million community members across 150+ countries and a portfolio that includes 27 unicorns like SpaceX, Robinhood, Carta, and Dapper Labs, Republic’s integration with Injective represents a pivotal moment in bridging traditional finance with on-chain innovation,” stated Injective.
INJ Price Outlook: Can Bulls Target $30?
Short-term technical indicators for INJ appear bearish, with both RSI and MACD signaling downward momentum.
Currently trading near $13, the price of Injective is closer to the lows of $6.90 seen in April 2025 than to the recent high of $34 reached in December 2024.
The selling pressure affecting Bitcoin and altcoins is not aiding bulls.
However, should market sentiment shift, a breakout above $20 could allow bulls to target the $30 mark.
Besides the partnership with Republic, other significant bullish drivers include heightened institutional interest and demand in the context of tokenization and real-world assets.
Injective’s quest to lead with new financial primitives designed to expand its DeFi capabilities, coupled with the market for Nvidia’s GPU derivatives, adds to the overall positive outlook.
Anticipation of ETF filings and approvals, along with whale accumulation, are also expected to be bullish for the price of Injective.
Bulls, however, need to remain above $13, and ideally $10, to avoid giving further momentum to bears.
Meet William, a proud Bethel University alumnus with a fervent passion for lifestyle and culture topics. His keen interest doesn’t stop there; he’s also deeply engrossed in current events of all kinds. William dedicates himself wholeheartedly to this site, thriving on the collaborative energy he shares with Suzanne, his long-standing partner in crime.
Having navigated their university courses side by side for years, their teamwork on the site is nothing short of dynamic. Together, they bring a unique blend of insights, proving that two heads are indeed better than one in delivering compelling content.
